South America Leukapheresis Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)


No. of Pages: 116    |    Report Code: TIPRE00025793    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
South America Leukapheresis Market
Buy Now

Market Introduction

The South America Leukapheresis market is analyzed based on three large countries: Brazil, Argentina, and rest of SAM. Brazil is contributing a major share in the growth of leukapheresis market. In Brazil, sickle cell is among the most common hereditary diseases. Every year, 700 to 1000 children in Brazil are known to be born with SCD. The disease’s most common type is sickle cell anemia (SCA), which occurs due to a single mutation in the β-globin gene. In Brazil, the occurrence of sickle cell anemia is varied, with a significantly higher incidence in states such as Maranhão with higher poverty indexes and more significant numbers among individuals of African descent. The country has also recorded a rise in the cases of leukemia among children during recent years. The cases of leukemia in Brazil have increased with time and at present, is the 9th most common cancer in the country. Its prevalence is found to be considerably high among males and causes from 41.7 to 57.5 cases per million inhabitants. Also, the proportion of leukemia cases among regions is highly variable in the country and has risen since the last report by published the Instituto Nacional do Câncer (INCA). The Northern part of Brazil was identified to have the second-highest number of leukemia cases. It also has the lowest municipal human development index (mHDI), hence leading the highest childhood mortality rate. Therefore, owing to the rise in cases of sickle cell anemia and leukemia, the country is expected to offer growth opportunities for the market during the forecast period.

South America have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, and Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Moreover, in South America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations, Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP to healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID?19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state?owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.


Get more information on this report

South America Leukapheresis Strategic Insights

Strategic insights for the South America Leukapheresis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-america-leukapheresis-market-strategic-framework.webp
Get more information on this report

South America Leukapheresis Report Scope

Report Attribute Details
Market size in 2021 US$ 4.92 Million
Market Size by 2028 US$ 7.89 Million
Global CAGR (2021 - 2028) 7.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Leukapheresis Devices
  • Leukapheresis Disposables
By Application
  • Research Applications
  • Therapeutic Applications
By End User
  • Blood Component Providers and Blood Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Transfusion Centers
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • BioIVT
  • Get more information on this report

    South America Leukapheresis Regional Insights

    The geographic scope of the South America Leukapheresis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-america-leukapheresis-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The leukapheresis market in South America is expected to grow from US$ 4.92 million in 2021 to US$ 7.89 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.

    Key Market Segments

    In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021.  Based on end user, blood component providers and blood centers segment held the largest share in 2021.

    Major Sources and Companies Listed

    A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; and BioIVT among others.

    Reasons to buy report

    • To understand the South America leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for South America leukapheresis market
    • Efficiently plan M&A and partnership deals in South America leukapheresis market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South America leukapheresis market
    • Obtain market revenue forecast for market by various segments from 2021-2028 in South America region.

     

    South America Leukapheresis Market Segmentation

     

    South America Leukapheresis Market – By Product Type

    • Leukapheresis Disposables
    • Leukapheresis Devices

    South America Leukapheresis Market – By Application

    • Research Applications
    • Therapeutic Applications

    South America Leukapheresis Market – By End User

    • Blood Component Providers and Blood Centers
    • Hospitals and Transfusion Centers
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes

     

    South America Leukapheresis Market – By Country

    • Brazil
    • Argentina
    • Rest of South America

    South America Leukapheresis Market – Companies Mentioned

    • Asahi Kasei Corporation                                 
    • Fresenius SE & Co. KGaA                                
    • Haemonetics Corporation                              
    • Terumo Corporation                                        
    • STEMCELL Technologies Inc.                          
    • HemaCare  
    • Macopharma
    • AllCells
    • STEMEXPRESS  
    • BioIVT                            

    The List of Companies - South America Leukapheresis Market

    1. Asahi Kasei Corporation                                 
    2. Fresenius SE & Co. KGaA                                
    3. Haemonetics Corporation                              
    4. Terumo Corporation                                        
    5. STEMCELL Technologies Inc.                          
    6. HemaCare  
    7. Macopharma
    8. AllCells
    9. BioIVT 
    Frequently Asked Questions
    How big is the South America Leukapheresis Market?

    The South America Leukapheresis Market is valued at US$ 4.92 Million in 2021, it is projected to reach US$ 7.89 Million by 2028.

    What is the CAGR for South America Leukapheresis Market by (2021 - 2028)?

    As per our report South America Leukapheresis Market, the market size is valued at US$ 4.92 Million in 2021, projecting it to reach US$ 7.89 Million by 2028. This translates to a CAGR of approximately 7.0% during the forecast period.

    What segments are covered in this report?

    The South America Leukapheresis Market report typically cover these key segments-

    • Product Type (Leukapheresis Devices, Leukapheresis Disposables)
    • Application (Research Applications, Therapeutic Applications)
    • End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers)

    What is the historic period, base year, and forecast period taken for South America Leukapheresis Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Leukapheresis Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Leukapheresis Market?

    The South America Leukapheresis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • BioIVT
  • Who should buy this report?

    The South America Leukapheresis Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Leukapheresis Market value chain can benefit from the information contained in a comprehensive market report.